REGULATED PRESS RELEASE published on 06/27/2024 at 17:45, 4 months 23 days ago Infotel announces the acquisition of a 30% stake in Altanna, an expert in complex IT infrastructure solutions. Infotel acquires 30% stake in Altanna, expert in complex IT infrastructure solutions. Deal fully financed in cash. Infotel specializes in digital transformation for major accounts Acquisition INFOTEL Digital Transformation Altanna IT Infrastructure Solutions
BRIEF published on 05/27/2024 at 16:32, 5 months 24 days ago Infotel: Proposed share buyback program INFOTEL External Growth Share Buyback General Assembly Eurolist Euronext Paris
BRIEF published on 05/22/2024 at 17:50, 5 months 29 days ago Infotel Reports Temporary Slowdown in Q1 2024 Revenue, Optimism for Second Half INFOTEL Digital Transformation Revenue Dividend Q1 2024
REGULATED PRESS RELEASE published on 05/22/2024 at 17:45, 5 months 29 days ago Infotel : Temporary slowdown in growth in Q1 2024. Optimism for the second half with a rebound expected. Distribution of a dividend of €2 per share for 2023. Infotel reports temporary slowdown in Q1 2024 revenue with plans for rebound in the second half. €2 dividend per share confirmed for 2023 INFOTEL Digital Transformation Revenue Dividend Slowdown
BRIEF published on 04/26/2024 at 17:50, 6 months 24 days ago Infotel Announces the Publication of Its 2023 Universal Registration Document INFOTEL Corporate Governance Annual Report Financial Markets Universal Registration Document
REGULATED PRESS RELEASE published on 04/26/2024 at 17:45, 6 months 24 days ago Publication of the 2023 Universal Registration Document Infotel announces the publication of its 2023 Universal Registration Document, including the Annual Report and corporate governance report. Event details and company overview provided. INFOTEL Digital Transformation AMF Financial Report Universal Registration Document
BRIEF published on 03/13/2024 at 17:50, 8 months 7 days ago Infotel Announces Steady Growth in 2023 Full-Year Results INFOTEL Digital Transformation Investment Strategy Dividend Proposal 2023 Financial Results
REGULATED PRESS RELEASE published on 03/13/2024 at 17:45, 8 months 7 days ago Infotel : 2023 full-year results - Revenue: €307.5m, +2.4%. Infotel announces 2023 full-year results with revenue of €307.5m, +2.4%. Operating profitability at 8.9% and net income of €18.1m. Dividend proposed: €2 per share. 2024 outlook: growth expected to resume in H2 INFOTEL Revenue Dividend 2023 Full-year Results Growth Outlook
REGULATED PRESS RELEASE published on 10/25/2023 at 17:45, 1 year ago Infotel : Business growth of +3.7% over 9 months in a slowing market. Optimal level of business activity maintained.
Published on 11/21/2024 at 13:30, 27 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 27 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 57 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 57 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 57 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 22 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 42 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo